Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,263 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 27,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 2,506 | $204.32 | $512,025.92 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,924 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.02 to $204.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 11,994 | $203.39 | $2,439,459.66 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,430 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.01 to $203.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:08 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 12,000 | $30.89 | $370,680.00 |
DisclosureSEC source: 0001555280-21-000295 · wf-form4_163001209828688.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 16:51 UTC |
Reed Willie MDirector
|
SaleCommon Stock | 1,450 | $207.10 | $300,295.00 |
DisclosureSEC source: 0001555280-21-000293 · wf-form4_162983828355544.xml · nonDerivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,964 F1 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 20:49 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 5,577 | $207.33 | $1,156,279.41 |
DisclosureSEC source: 0001555280-21-000291 · wf-form4_162983818091613.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,874 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.00 to $207.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 20:49 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 4,026 | $206.71 | $832,214.46 |
DisclosureSEC source: 0001555280-21-000291 · wf-form4_162983818091613.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,451 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021. F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.00 to $206.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 31, 2021 Filed Aug 18, 2021 20:24 UTC |
Nayak Abhay UExecutive Vice President
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,764.8277 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · derivative · entry 3 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266.9807 Underlying: Common Stock · 1,764.8277 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 1,764.8277 RSUs vested on July 31, 2021; 289.0936 RSUs will vest on February 12, 2022; 393.2935 RSUs will vest on February 11, 2023; and 584.5936 RSUs will vest on February 10, 2024. Read SEC document |
| July 31, 2021 Filed Aug 18, 2021 20:24 UTC |
Nayak Abhay UExecutive Vice President
|
Tax withholdingCommon Stock | 605 | $202.70 | $122,633.50 |
DisclosureSEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · nonDerivative · entry 2 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,159 Read SEC document |
| July 31, 2021 Filed Aug 18, 2021 20:24 UTC |
Nayak Abhay UExecutive Vice President
|
Exercise / conversionCommon Stock | 1,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000289 · wf-form4_162931828363754.xml · nonDerivative · entry 1 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:56 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 12,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,860 Underlying: Common Stock · 12,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:56 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 5,640 | $199.69 | $1,126,251.60 |
DisclosureSEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,477 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.49 to $200.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:56 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 16,810 | $199.01 | $3,345,358.10 |
DisclosureSEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,117 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.49 to $199.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 21:56 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 12,844 | $55.02 | $706,676.88 |
DisclosureSEC source: 0001555280-21-000278 · wf-form4_162733655284883.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 18:15 UTC |
Pudloski Sherry NExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 92.5905 | $61.79 | $5,721.17 |
DisclosureSEC source: 0001555280-21-000276 · wf-form4_162681929200982.xml · derivative · entry 1 Pudloski Sherry N · CIK 0001806929 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149.4267 Underlying: Common Stock · 28.6517 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:14 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
GrantPhantom Stock Unit · Derivative | 261.4323 | $61.79 | $16,153.90 |
DisclosureSEC source: 0001555280-21-000275 · wf-form4_162681923897198.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,573.9527 Underlying: Common Stock · 80.8989 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:13 UTC |
Nayak Abhay UExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 87.1448 | $61.79 | $5,384.68 |
DisclosureSEC source: 0001555280-21-000274 · wf-form4_162681919432793.xml · derivative · entry 1 Nayak Abhay U · CIK 0001797754 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543.7424 Underlying: Common Stock · 26.9665 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:12 UTC |
Mamilli WafaaExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 130.7161 | $61.79 | $8,076.95 |
DisclosureSEC source: 0001555280-21-000273 · wf-form4_162681913840517.xml · derivative · entry 1 Mamilli Wafaa · CIK 0001800960 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,568.7733 Underlying: Common Stock · 40.4495 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:11 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 122.0021 | $61.79 | $7,538.51 |
DisclosureSEC source: 0001555280-21-000272 · wf-form4_162681907396787.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,906.0239 Underlying: Common Stock · 37.753 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:08 UTC |
Knupp Catherine A.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 154.6809 | $61.79 | $9,557.73 |
DisclosureSEC source: 0001555280-21-000270 · wf-form4_162681890206823.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,209.662 Underlying: Common Stock · 47.8652 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:07 UTC |
David GlennExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 157.9492 | $61.79 | $9,759.68 |
DisclosureSEC source: 0001555280-21-000269 · wf-form4_162681885868056.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,038.5376 Underlying: Common Stock · 48.8766 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:07 UTC |
Chen Heidi C.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 133.9845 | $61.79 | $8,278.90 |
DisclosureSEC source: 0001555280-21-000268 · wf-form4_162681881301359.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,832.4255 Underlying: Common Stock · 41.4608 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:06 UTC |
Bettington Timothy JExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 122.0021 | $61.79 | $7,538.51 |
DisclosureSEC source: 0001555280-21-000267 · wf-form4_162681875563686.xml · derivative · entry 1 Bettington Timothy J · CIK 0001797894 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573.4707 Underlying: Common Stock · 37.753 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,896 Underlying: Common Stock · 3,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 3,287 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC |
Trawicki RomanExecutive Vice President
|
SaleCommon Stock | 4,492 | $187.00 | $840,004.00 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,210 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:22 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionCommon Stock | 3,285 | $73.24 | $240,593.40 |
DisclosureSEC source: 0001555280-21-000257 · wf-form4_162560287244851.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:28 UTC |
Joseph WettenyChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 7,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 2 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,366 Underlying: Common Stock · 7,512 shares Expires not disclosed F5 · security: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F6 · derivative.exercise_date: Each vested restricted stock unit will be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: Represents vested restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to earlier settlement upon certain specific events. Dividend equivalent units are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to earlier settlement upon certain specific events. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:28 UTC |
Joseph WettenyChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 19,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000255 · wf-form4_162525769654890.xml · derivative · entry 1 Joseph Wetteny · CIK 0001285781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,854 Underlying: Common Stock · 19,854 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each restricted stock unit will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F1 · balance_after: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. These restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 20:34 UTC |
SCULLY ROBERT WDirector
|
GrantPhantom Stock Unit · Derivative | 168.5727 | $185.38 | $31,250.01 |
DisclosureSEC source: 0001555280-21-000253 · wf-form4_162465324708877.xml · derivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,472.5318 Underlying: Common Stock · 168.5727 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service. Read SEC document |
| June 04, 2021 Filed Jun 23, 2021 20:25 UTC |
Chen Heidi C.Executive Vice President
|
GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000248 · wf-form4_162447991484551.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,095 Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · derivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,263 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 12,000 options granted March 4, 2014 at an exercise price of $30.89 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 39,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 4,900 | $175.94 | $862,106.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,424 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.70 to $176.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
SaleCommon Stock | 9,600 | $175.20 | $1,681,920.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,324 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.69 to $175.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:16 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 12,000 | $30.89 | $370,680.00 |
DisclosureSEC source: 0001555280-21-000241 · wf-form4_162206378619818.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:39 UTC |
Knupp Catherine A.Executive Vice President
|
SaleCommon Stock | 8,283 | $175.16 | $1,450,850.28 |
DisclosureSEC source: 0001555280-21-000234 · wf-form4_162162956453502.xml · nonDerivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,642 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $174.95 to $175.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:20 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,702.937 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · derivative · entry 4 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,702.937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F8 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F9 · derivative.expiration_date: Not applicable. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:20 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionDeferred Stock Unit · Derivative | 10,469.5783 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · derivative · entry 3 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,469.5783 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents deferred stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs were fully vested on the date of the grant and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis. F4 · derivative.exercise_price: Each DSU represents a contingent right to receive one share of Zoetis Inc. common stock. F5 · derivative.exercise_date: Each DSU will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director of Zoetis Inc. F5 · derivative.expiration_date: Each DSU will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director of Zoetis Inc. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:20 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 5,702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · nonDerivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:20 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 10,468 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000238 · wf-form4_162189119888556.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of deferred stock units (DSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each DSU represents a right to receive one share of Zoetis Inc. common stock upon settlement of the DSU. F1 · price: Acquisition of common stock upon vesting and settlement of deferred stock units (DSUs) in connection with Mr. Steere's retirement from the Zoetis Board of Directors. Each DSU represents a right to receive one share of Zoetis Inc. common stock upon settlement of the DSU. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:22 UTC |
Alaix Juan RamonDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,302.2257 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,783.8375 Underlying: Common Stock · 1,302.2257 shares Expires not disclosed F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5 · derivative.expiration_date: Not applicable. F7 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:22 UTC |
Alaix Juan RamonDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 130.8769 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,086.0632 Underlying: Common Stock · 130.8769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5 · derivative.expiration_date: Not applicable. F6 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:22 UTC |
Alaix Juan RamonDirector
|
Exercise / conversionCommon Stock | 130 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:41 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 4,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · derivative · entry 5 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,704 Underlying: Common Stock · 4,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 4,638 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:41 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 1,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · derivative · entry 4 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,342 Underlying: Common Stock · 1,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:41 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 6,000 | $169.05 | $1,014,300.00 |
DisclosureSEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,083 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:41 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 4,638 | $55.02 | $255,182.76 |
DisclosureSEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:41 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 1,362 | $41.83 | $56,972.46 |
DisclosureSEC source: 0001555280-21-000235 · wf-form4_162162968922886.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 5 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,136 Underlying: Common Stock · 728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 728 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 5,824 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC |
Kelly Robert EdwardExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · derivative · entry 4 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,864 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 820 options granted January 31, 2013 at an exercise price of $26.00 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 6,560 options granted January 31, 2013 at an exercise price of $26.00 per option; 6,552 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:21 UTC |
Kelly Robert EdwardExecutive Vice President
|
SaleCommon Stock | 2,053 | $174.70 | $358,659.10 |
DisclosureSEC source: 0001555280-21-000218 · wf-form4_162015960623725.xml · nonDerivative · entry 3 Kelly Robert Edward · CIK 0001798683 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,300 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.